An update on alcohol and atherosclerosis.

Area of Science:

• Cardiovascular epidemiology
• Nutritional science
• Genetics

Background:

• Epidemiological studies consistently associate moderate alcohol intake with decreased cardiovascular disease (CVD) risk.
• Controversies persist regarding non-alcoholic constituents, genetic influences, mechanisms, and experimental validation.

Purpose of the Study:

• To review the current understanding of the relationship between moderate alcohol consumption and cardiovascular health.
• To explore the roles of high-density lipoprotein cholesterol (HDL-C), inflammatory factors, and genetic variations.
• To assess the potential impact of non-alcoholic beverage components.

Main Methods:

• Review of epidemiological studies and recent scientific evidence.
• Analysis of findings from experimental models, including animal studies.
• Examination of genetic factors, such as apolipoprotein E and interleukin 6 gene variants.

Main Results:

• Moderate alcohol use shows inverse relationships with inflammatory factors and influences high-density lipoprotein cholesterol (HDL-C).
• Animal models partially confirm ethanol's anti-atherogenic effects, implicating inflammatory pathways.
• Non-alcoholic components, particularly from red wine, demonstrate potential in vitro benefits, though human relevance is uncertain.
• Genetic factors may modulate alcohol's impact on atherosclerosis, highlighting HDL-C and inflammation as mediators.

Conclusions:

• The association between moderate drinking and reduced CVD risk warrants continued investigation.
• Future research should focus on gene-environment interactions and the translational potential of non-alcoholic compounds.